SCHEMBL10993476

SCHEMBL10993476

COCC(=O)NS

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12522543 0.77 NPSR1 (0.46)
SCHEMBL4982425 0.74
SCHEMBL103430 0.74
SCHEMBL10993867 0.74
SCHEMBL2730627 0.72 SPR (0.49)
SCHEMBL10716348 0.72
SCHEMBL18774433 0.72
SCHEMBL1561807 0.72
SCHEMBL166515 0.72
SCHEMBL8582117 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110243892-A1 Y-SHAPE BRANCHED HYDROPHILIC POLYMER DERIVATIVES, THEIR PREPARATION METHODS, CONJUGATES OF THE DERIVATIVES AND DRUG MOLECULES, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE CONJUGATES JI SHISHAN 2011-10-06 US disclosed
US-8003089-B2 such as triethanolamine with 2 hydroxyethyl groups derivatized with polyethylene glycol, and the amine group conjugated to drugs such as antitumor agent interferon BEIJING JIANKAI TECHNOLOGY CO., LTD. (CN) 2011-08-23 US disclosed
US-4518597-A THROMBOSIS, ARTERIOSCLEROSIS, ANTITUMOR, ANTICOAGULANTS DR. KARL THOMAE GMBH (DE) 1985-05-21 US disclosed